Biomerieux (France) Analysis
| BIM Stock | EUR 91.55 0.40 0.44% |
Biomerieux SA is overvalued with Real Value of 79.78 and Hype Value of 91.55. The main objective of Biomerieux stock analysis is to determine its intrinsic value, which is an estimate of what Biomerieux SA is worth, separate from its market price. There are two main types of Biomerieux's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biomerieux's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biomerieux's stock to identify patterns and trends that may indicate its future price movements.
The Biomerieux stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biomerieux's ongoing operational relationships across important fundamental and technical indicators.
Biomerieux |
Biomerieux Stock Analysis Notes
About 64.0% of the company shares are held by company insiders. The book value of Biomerieux was currently reported as 29.31. The company has Price/Earnings To Growth (PEG) ratio of 2.9. Biomerieux SA last dividend was issued on the 6th of June 2022. The entity had 3:1 split on the 20th of September 2017. bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people. For more info on Biomerieux SA please contact Alexandre Merieux at 33 4 78 87 20 00 or go to https://www.biomerieux.com.Biomerieux SA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biomerieux's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomerieux SA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Biomerieux SA generated a negative expected return over the last 90 days | |
| About 64.0% of the company shares are held by company insiders |
Biomerieux Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerieux's market, we take the total number of its shares issued and multiply it by Biomerieux's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biomerieux Profitablity
Biomerieux's profitability indicators refer to fundamental financial ratios that showcase Biomerieux's ability to generate income relative to its revenue or operating costs. If, let's say, Biomerieux is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biomerieux's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biomerieux's profitability requires more research than a typical breakdown of Biomerieux's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21. Technical Drivers
As of the 12th of June 2024, Biomerieux shows the Risk Adjusted Performance of (0.03), standard deviation of 1.65, and Mean Deviation of 1.05. Biomerieux SA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biomerieux SA Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biomerieux middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biomerieux SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biomerieux Predictive Daily Indicators
Biomerieux intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biomerieux stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1042.05 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 92.15 | |||
| Day Typical Price | 91.95 | |||
| Price Action Indicator | (0.80) | |||
| Period Momentum Indicator | (0.40) |
Biomerieux Forecast Models
Biomerieux's time-series forecasting models are one of many Biomerieux's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomerieux's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biomerieux Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biomerieux prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biomerieux shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biomerieux. By using and applying Biomerieux Stock analysis, traders can create a robust methodology for identifying Biomerieux entry and exit points for their positions.
bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biomerieux to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Complementary Tools for Biomerieux Stock analysis
When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |